These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26319548)

  • 1. Bayesian population modeling of drug dosing adherence.
    Fellows K; Stoneking CJ; Ramanathan M
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):515-25. PubMed ID: 26319548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid Markov chain-von Mises density model for the drug-dosing interval and drug holiday distributions.
    Fellows K; Rodriguez-Cruz V; Covelli J; Droopad A; Alexander S; Ramanathan M
    AAPS J; 2015 Mar; 17(2):427-37. PubMed ID: 25609224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics.
    Dodds MG; Vicini P
    Ann Biomed Eng; 2004 Sep; 32(9):1300-13. PubMed ID: 15493516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian method for construction of Markov models to describe dynamics on various time-scales.
    Rains EK; Andersen HC
    J Chem Phys; 2010 Oct; 133(14):144113. PubMed ID: 20949993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.
    Schmidt PJ; Pintar KD; Fazil AM; Topp E
    Risk Anal; 2013 Sep; 33(9):1677-93. PubMed ID: 23311599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian restoration of a hidden Markov chain with applications to DNA sequencing.
    Churchill GA; Lazareva B
    J Comput Biol; 1999; 6(2):261-77. PubMed ID: 10421527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gradient Markov chain Monte Carlo algorithm for computing multivariate maximum likelihood estimates and posterior distributions: mixture dose-response assessment.
    Li R; Englehardt JD; Li X
    Risk Anal; 2012 Feb; 32(2):345-59. PubMed ID: 21906114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the reliability of NMR relaxation data analyses: a Markov Chain Monte Carlo approach.
    Abergel D; Volpato A; Coutant EP; Polimeno A
    J Magn Reson; 2014 Sep; 246():94-103. PubMed ID: 25117152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approximate Bayesian computation (ABC) gives exact results under the assumption of model error.
    Wilkinson RD
    Stat Appl Genet Mol Biol; 2013 May; 12(2):129-41. PubMed ID: 23652634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating digital medicine ingestion data from seriously mentally ill patients with a Bayesian Hybrid Model.
    Knights J; Heidary Z; Peters-Strickland T; Ramanathan M
    NPJ Digit Med; 2019; 2():20. PubMed ID: 31304367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian semiparametric intensity estimation for inhomogeneous spatial point processes.
    Yue YR; Loh JM
    Biometrics; 2011 Sep; 67(3):937-46. PubMed ID: 21175553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Monte Carlo method for calculating Bayesian uncertainties in internal dosimetry.
    Puncher M; Birchall A
    Radiat Prot Dosimetry; 2008; 132(1):1-12. PubMed ID: 18806256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
    Jordan P; Brunschwig H; Luedin E
    Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal Bayesian nonparametric model for time to disease arrival of threatened amphibian populations.
    Zhou H; Hanson T; Knapp R
    Biometrics; 2015 Dec; 71(4):1101-10. PubMed ID: 26148536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Bayesian Markov Chain Monte Carlo methods to model cost-of-illness data.
    Cooper NJ; Sutton AJ; Mugford M; Abrams KR
    Med Decis Making; 2003; 23(1):38-53. PubMed ID: 12583454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A semi-parametric Bayesian model for semi-continuous longitudinal data.
    Ren J; Tapert S; Fan CC; Thompson WK
    Stat Med; 2022 Jun; 41(13):2354-2374. PubMed ID: 35274335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Bayesian population physiologically based pharmacokinetic (PBPK) modeling and Markov chain Monte Carlo simulations to pesticide kinetics studies in protected marine mammals: DDT, DDE, and DDD in harbor porpoises.
    Weijs L; Yang RS; Das K; Covaci A; Blust R
    Environ Sci Technol; 2013 May; 47(9):4365-74. PubMed ID: 23560461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Thurstonian model for quantitative genetic analysis of ranks: a Bayesian approach.
    Gianola D; Simianer H
    Genetics; 2006 Nov; 174(3):1613-24. PubMed ID: 16980397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing variational Bayes with Markov chain Monte Carlo for Bayesian computation in neuroimaging.
    Nathoo FS; Lesperance ML; Lawson AB; Dean CB
    Stat Methods Med Res; 2013 Aug; 22(4):398-423. PubMed ID: 22642986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.